Case Report
Evolution of Choroidal Neovascularization due to Presumed Ocular Histoplasmosis Syndrome on Multimodal Imaging including Optical Coherence Tomography Angiography
Figure 4
Fluorescein angiography (late frame) at the patient’s baseline visit (VA 20/70, bevacizumab #1 given) (a); 2-month visit (VA 20/32, bevacizumab #3 given) (b); 4-month visit (VA 20/25) (c); 6-month visit (VA 20/20) (d). After the 2-month visit, there is complete resolution of leakage. VA = visual acuity.
(a) |
(b) |
(c) |
(d) |